Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
Apply
Durvalumab & Tremelimumab & SBRT
Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step